SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, India

202274 citationsJournal Articlegold Open Access

Authors

Sumit Malhotra · All India Institute of Medical Sciences

Kalaivani Mani · All India Institute of Medical Sciences

Rakesh Lodha · All India Institute of Medical Sciences

Sameer Bakhshi · All India Institute of Medical Sciences

Vijay Prakash Mathur · All India Institute of Medical Sciences

Pooja Gupta · All India Institute of Medical Sciences

Saurabh Kedia

Abstract

These findings suggest that BBV152 was associated with protection against both symptomatic and asymptomatic reinfection in HCWs after a complete vaccination schedule, when the predominant circulating variant was B.1.617.2.

Topics & Keywords

SARS-CoV-2 and COVID-19 Research Vaccine Coverage and Hesitancy COVID-19 epidemiological studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Network Open

Volume 5, Issue 1, pp. e2142210-e2142210

DOI: 10.1001/jamanetworkopen.2021.42210

Field-Weighted Citation Impact: 7.38